The EPS projection of Thermo Fisher Scientific Inc (NYSE:TMO) for quarter ended 2016-09-30 is $2.03. Last week, the projection for EPS was $2.03 against target of $2.03, a month earlier. While 2-months ago, this projection was $2.03 versus forecast of $2.03a quarter months earlier, posting a deviation of 0%.
Thermo Fisher Scientific Inc (NYSE:TMO) posted that 18 days earlier, the share price was revised 2 times on upside. In addition, negative revisions were 1.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 8, and 8, correspondingly.
The per-share earnings downgrade for Thermo Fisher Scientific Inc (NYSE:TMO) in the preceding 30 and 120 were 0 and 0. While in 60 and 90 days were 0, and 0, in that order.
Thermo Fisher Scientific Inc (NYSE:TMO) EPS target was $2.03 for the quarter closed 1. It was based on 11 calls. As on 2016-04-28 the EPS was $1.8. The change was $0.06, posting a deviation of 3.45%. The price projections gave a standard deviation of 0.02.
Quarterly Sales Estimates
Thermo Fisher Scientific Inc (NYSE:TMO) sales prediction for the fiscal 2017 stands at $4984.35 and the median estimate is at $4984.35. Almost 2 analysts gave sales target.
Among this, the highest sales estimate is $5030 while the lowest target is $4938.7 showing standard deviation of 64.558%.
As many as 2 analysts have positive sales targets revision while 2 reduced sales estimates, posting a deviation of 0%.
Last month, 2 experts have positive sales number revision. Also, 2 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast, posting a deviation of -0.218%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...